Sugimoto, W.; Itoh, K.; Hirata, H.; Abe, Y.; Torii, T.; Mitsui, Y.; Budirahardja, Y.; Tanaka, N.; Kawauchi, K.
MMP24 as a Target of YAP Is a Potential Prognostic Factor in Cancer Patients. Bioengineering 2020, 7, 18.
https://doi.org/10.3390/bioengineering7010018
AMA Style
Sugimoto W, Itoh K, Hirata H, Abe Y, Torii T, Mitsui Y, Budirahardja Y, Tanaka N, Kawauchi K.
MMP24 as a Target of YAP Is a Potential Prognostic Factor in Cancer Patients. Bioengineering. 2020; 7(1):18.
https://doi.org/10.3390/bioengineering7010018
Chicago/Turabian Style
Sugimoto, Wataru, Katsuhiko Itoh, Hiroaki Hirata, Yoshinori Abe, Takeru Torii, Yasumasa Mitsui, Yemima Budirahardja, Nobuyuki Tanaka, and Keiko Kawauchi.
2020. "MMP24 as a Target of YAP Is a Potential Prognostic Factor in Cancer Patients" Bioengineering 7, no. 1: 18.
https://doi.org/10.3390/bioengineering7010018
APA Style
Sugimoto, W., Itoh, K., Hirata, H., Abe, Y., Torii, T., Mitsui, Y., Budirahardja, Y., Tanaka, N., & Kawauchi, K.
(2020). MMP24 as a Target of YAP Is a Potential Prognostic Factor in Cancer Patients. Bioengineering, 7(1), 18.
https://doi.org/10.3390/bioengineering7010018